Home ›  IPO Research & Reviews ›  Crystal Crop Protection IPO Review 


  By IndiaIPOHub Research Desk • Updated: November 13, 2026 • Source: Red Herring Prospectus (RHP) 


  Disclosure & Disclaimer: IndiaIPOHub is not a SEBI-registered Research Analyst or Investment Adviser. The analysis below represents independent educational research compiled from Crystal Crop Protection Limited's Red Herring Prospectus (RHP) and public exchange filings. Investors must conduct their own independent research or consult a SEBI-registered financial adviser before making any investment decision. 

  

Crystal Crop Protection IPO — RHP Key Highlights

   

    Bidding Window    Nov 18 – Nov 20, 2026      

    Price Band    ₹259 – ₹272 per share  

    Total Issue Size (at ₹272)    ₹455.49 Cr (Fresh: ₹354.77 Cr | OFS: ₹100.71 Cr)   

    Minimum Retail Lot    55 Shares (₹14,960 at cap price)   

  

  View Live QIB / NII / Retail Subscription Status → 

  

  Crystal Crop Protection Limited is launching its ₹455.49 crore initial public offering on the BSE and NSE between November 18 and November 20, 2026, in a price band of ₹259 to ₹272 per equity share. Backed by International Finance Corporation (IFC), the Delhi-based agri-inputs player has grown its revenue from operations from ₹2,229.93 crore in FY24 to ₹3,151.97 crore in FY26, while expanding EBITDA margins from 9.38% to 14.47%. While 77.89% of the issue is a Fresh Issue earmarked heavily for debt reduction, prospective investors should carefully evaluate the RHP's qualified auditor opinions, ongoing CBI/ED litigation disclosures, and high Chinese raw-material import reliance before taking an independent decision. 


  

1. About Crystal Crop Protection Limited & Core Business Model

 Promoted by Nand Kishore Aggarwal and Ankur Aggarwal, Crystal Crop Protection Limited is an R&D-focused Indian crop protection, natural crop solutions, and hybrid seeds company. The company operates a dual-brand distribution architecture—Crystal and Saffire—through non-overlapping channels supported by a dedicated field force of 729 crop protection and 489 seeds sales executives.  

  • Crop Protection Formulations (174+ Brands): Manufactures and sells herbicides, fungicides, and insecticides in farmer-friendly pack sizes. Growth has been bolstered by acquiring legacy brands from global agrochemical majors, including Bavistin, Gramoxone, Proclaim, and Furadan.  
  • Crop Nutrition & Biologicals: Supplies bio-stimulants, bio-protectants, plant growth regulators (PGRs), micronutrients, and liquid fertilizers.  
  • Seeds & Exports: Develops and markets cotton, cereals, oilseeds, fodder, vegetable, and flower seeds across India, with exports reaching markets such as the USA, Japan, and Thailand.  
  • R&D & Intellectual Property: Operates a GLP-approved R&D facility (KRDC) with a portfolio of 28 filed patents focused on backward integration and off-patent active ingredients.

  

2. IPO Structure & Objects of the Issue

At the upper price band of ₹272 per share, Crystal Crop Protection is raising ₹455.49 crore, structured predominantly as primary capital to de-leverage its balance sheet: 

Component / ObjectAmount (₹ Crore)% of Total IssueAnalytical Takeaway
Fresh Issue₹354.77 Cr77.89%Enters company balance sheet primarily for debt reduction
Offer for Sale (OFS)₹100.71 Cr (37.03 lakh shares)22.11%Partial stake sale by promoter Ankur Aggarwal
Object 1: Company Debt Repayment₹247.94 Cr54.43%Retires standalone borrowings, lowering annual interest outgo
Object 2: Subsidiary Debt Repayment₹22.06 Cr4.84%Investment in Saffire Crop Science Pvt Ltd to pay off debt
Object 3: Inorganic Growth & GCP₹84.77 Cr (approx.)18.61%Unidentified brand/business acquisitions & general corporate purposes

 

3. Financial Performance (Restated Consolidated RHP Data)

   Between FY24 and FY26, Crystal Crop Protection's revenue from operations compounded at 18.9% CAGR, while Profit After Tax (PAT) grew from ₹87.24 crore to ₹144.91 crore. In Q1 FY27 (quarter ended June 30, 2026), strong seasonal Kharif demand lifted PAT to ₹135.78 crore on revenue from operations of ₹1,197.15 crore: 

Financial Metric (₹ Crore)FY24FY25FY26Q1 FY27 (3M)
Revenue from Operations₹2,229.93₹2,690.51₹3,151.97₹1,197.15
Total Income₹2,271.71₹2,731.94₹3,180.98₹1,209.21
EBITDA₹209.06₹315.28₹456.23₹241.78
EBITDA Margin (% of Operating Rev)9.38%11.72%14.47%20.20%
Profit After Tax (PAT)₹87.24₹118.39₹144.91₹135.78
Net Worth₹1,488.39₹1,600.10₹2,039.76—
Total Borrowings₹577.29₹947.02₹820.04₹952.02


4. Valuation & Listed Peer Comparison

   At the upper price band of ₹272 per share, Crystal Crop Protection commands a pre-issue P/E multiple of 28.19x based on FY26 basic EPS of ₹9.65 (and 24.59x on diluted FY26 EPS of ₹11.06), implying a post-issue market capitalization of roughly ₹4,438 crore:

Company NameRevenue from Ops (₹ Cr)P/E Ratio (x)RoNW (%)NAV / Share (₹)
Crystal Crop Protection Ltd (at ₹272)₹3,151.9728.19x (FY26)7.14%₹160.03
Dhanuka Agritech Ltd₹2,019.7914.38x17.67%₹372.89
Rallis India Ltd₹2,896.6519.93x6.16%₹104.40
Bayer CropScience Ltd₹5,675.0022.73x19.15%₹659.89
Sumitomo Chemical India Ltd₹3,238.3231.20x14.95%₹67.84
Kaveri Seed Company Ltd₹1,394.7612.13x16.07%₹341.53


   Valuation Observation: On trailing FY26 earnings, Crystal Crop Protection's asking P/E of 28.19x is priced at a premium to domestic peers such as Dhanuka Agritech (14.38x) and Rallis India (19.93x), while its FY26 RoNW of 7.14% trails most listed peers. Note that Q1 FY27 delivered an unusually strong seasonal PAT of ₹135.78 crore (which distorts annualized P/E downward to 8.17x); because agrochemical profits are heavily skewed toward Q1/Q2 Kharif sowing, full-year FY26 earnings remain the more conservative valuation anchor. 


5. Independent Research: Key Strengths vs. RHP Risk Factors


Key Fundamental Positives   

  • Consistent Margin Expansion: EBITDA margins expanded over 500 bps from 9.38% in FY24 to 14.47% in FY26, supported by backward integration and scaling of acquired brands like Bavistin.
  • Meaningful Debt Reduction: ₹270 crore of the ₹354.77 crore Fresh Issue directly retires standalone and subsidiary debt (out of ₹952.02 crore Q1 FY27 borrowings), which will lower finance costs.   
  • Positive Operating Cash Flows: Generated positive cash flow from operations across FY24 (₹337.79 Cr), FY25 (₹383.03 Cr), and FY26 (₹256.42 Cr) despite industry headwinds.   
  • Dual-Brand Distribution Moat: Non-overlapping Crystal and Saffire dealer channels backed by 1,200+ field executives drive deeper rural penetration. 

  

Key RHP Risk Factors  

  • Qualified Auditor Opinions: Statutory auditors issued qualified opinions across FY24, FY25, FY26, and Q1 FY27 regarding an improperly recognized ₹16.30 crore insurance claim receivable and internal financial control weaknesses.    
  • Ongoing CBI & ED Proceedings: Criminal and regulatory proceedings are active against the company and promoters over alleged Terminal Excise Duty refund claims of ₹75.53 crore, with ₹30.21 crore in fixed deposits provisionally attached by the ED.    
  • China Import Dependence: 48.84% of international raw material costs are sourced from Chinese suppliers, exposing margins to supply-chain and currency shocks.    
  • Monsoon Seasonality & Litigation: Aggregate outstanding litigation stands at ₹341.95 crore (16.76% of net worth), alongside high Kharif monsoon sensitivity.

 

  

6. IPO Timeline, Lot Size & Registrar Details

Event / ParameterDate / Details
IPO Open & Close DatesNovember 18, 2026 – November 20, 2026
Basis of AllotmentNovember 23, 2026
Refunds & Demat CreditNovember 25, 2026
Listing Date (BSE & NSE)November 26, 2026
Retail Lot Size (Min / Max)Min: 1 Lot = 55 Shares (₹14,960) | Max: 13 Lots = 715 Shares (₹1,94,480)
S-HNI / B-HNI MinimumS-HNI: 14 Lots (770 Shares = ₹2,09,440) | B-HNI: 67 Lots (3,685 Shares = ₹10,02,320)
Employee Discount₹25 per equity share
IPO Registrar & BRLMsRegistrar: MUFG Intime India Pvt Ltd | BRLMs: IIFL Capital, DAM Capital, Motilal Oswal

7. Frequently Asked Questions (FAQs)


What are the opening, closing, allotment, and listing dates for Crystal Crop Protection IPO?

  Crystal Crop Protection IPO opens for public bidding on November 18, 2026, and closes on November 20, 2026. The basis of allotment is scheduled for November 23, 2026, with refunds and demat credit on November 25, 2026, and listing on BSE and NSE expected on November 26, 2026.

 

What is the price band and minimum lot size for Crystal Crop Protection IPO?

The price band for Crystal Crop Protection IPO is fixed at ₹259 to ₹272 per equity share (face value ₹10), with an employee discount of ₹25 per share. The minimum retail lot size is 55 shares, requiring an application amount of ₹14,960 at the upper price band of ₹272.

 

What is the total issue size and Fresh Issue vs. OFS split of Crystal Crop Protection IPO?

At the upper price band of ₹272, the total issue size is ₹455.49 crore, comprising a Fresh Issue of ₹354.77 crore (77.89%) and an Offer for Sale (OFS) of 3,702,694 equity shares aggregating to ₹100.71 crore (22.11%) by promoter Ankur Aggarwal.

 

How will Crystal Crop Protection utilize the Fresh Issue proceeds?

Per the Red Herring Prospectus (RHP), Crystal Crop Protection will allocate ₹247.94 crore toward repayment or prepayment of its own borrowings, ₹22.06 crore for investment in material subsidiary Saffire Crop Science Private Limited to repay its borrowings, and the balance toward inorganic growth via unidentified acquisitions and general corporate purposes.

 

  

  Regulatory Disclaimer: IndiaIPOHub (indiaipohub.com) is an independent financial information and research platform. We are not registered with the Securities and Exchange Board of India (SEBI) as a Research Analyst (RA) or Investment Adviser (IA). All financial figures, peer comparisons, and analytical observations in this review are compiled strictly from Crystal Crop Protection Limited's Red Herring Prospectus (RHP) and public stock exchange disclosures for educational and informational purposes only. Nothing in this article constitutes an investment recommendation, solicitation, or offer to buy, sell, or subscribe to any security. IPO and equity investments are subject to market risks—investors are strongly advised to read the RHP in full and perform their own independent research before making any financial decision.